2015•Rheumatology InternationalRequires access

Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis

Wanruchada Katchamart, Ajchara Koolvisoot, Emvalee Aromdee, Praveena Chiowchanwesawakit, Chayawee Muengchan

Open publisher page 76 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 76 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Rheumatoid factor, Rheumatoid arthritis, Internal medicine, Rheumatology, Methotrexate

Back to paper search Browse research topics Original source

Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis — Research Paper | ScholarLens